TG Therapeutics, Inc. (BIT:1TGTX)
Italy flag Italy · Delayed Price · Currency is EUR
40.00
+0.78 (1.99%)
At close: May 2, 2025

TG Therapeutics Revenue

In the year 2024, TG Therapeutics had annual revenue of $329.00M USD with 40.80% growth. TG Therapeutics had revenue of $108.19M in the quarter ending December 31, 2024, with 146.04% growth.

Revenue
$329.00M
Revenue Growth
+40.80%
P/S Ratio
19.14
Revenue / Employee
$973.38K
Employees
338
Market Cap
6.08B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024329.00M95.34M40.80%
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020152.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Intesa Sanpaolo 25.38B
UniCredit 23.99B
Enel SpA 75.71B
Ferrari 6.68B
Assicurazioni Generali 55.30B
Eni S.p.A. 90.96B
Leonardo S.p.a. 17.76B
Stellantis 156.88B
Revenue Rankings